WNT5A and non-small cell lung carcinoma: The additional signals could also include for example different levels of Wnt11 receptor Fzd-7 in NSCLC sub-types that was detected in the AC and SCC samples (unpublished observations), as well as activators of e.g. the SP1, AP1 or AP2 transcription factors that could modify Wnt5a transcription.